MACDONALD ALISTAIR (Chief Executive Officer) received a stock award from SYNEOS HEALTH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/20/2022ACC: 0001209191-22-004114
DirectorOfficer· Chief Executive Officer
Since Jul 2018
+15.47K
Net shares
Net buyer
$1.29M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
30.50K acquired · 15.03K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−15.03K
Price / share
$86.09
Trade value
$1.29M
% of position
8.1%
1/18/2022
185.61K→170.58K
Class A Common Stock
Direct
Shares
+30.50K
Price / share
—
Trade value
—
% of position
17.9%
1/18/2022
170.58K→201.08K
Total
Net shares
+15.47K
Net value
-$1.29M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 1/18/2022 | F · Tax Withholding | −15.03K | $86.09 | $1.29M | 8.1% | 185.61K | 170.58K |
| Class A Common Stock Direct | 1/18/2022 | A · Award | +30.50K | — | — | 17.9% | 170.58K | 201.08K |
| Total | +15.47K | -$1.29M | ||||||
Derivative Transactions0
No derivative transactions reported